Dr. Benny Baeten, Compound Development Team Leader for Anthelminthics at the Janssen Pharmaceutical Companies of Johnson & Johnson speaks to the ISNTD about current research at J&J on antihelmintihcs and the future partnerships at Janssen for NTDs.
Recorded at ISNTD d³ on May 16th 2017 at the Wellcome Trust London.
…………………………………………………….
For more information please contact:
Kamran Rafiq
#NTDs #drugdiscovery #STH #SoilTransmittedHelminths #Africa #onchocerciasis #JohnsonJohnson